Takeshi Sudo
Impact in
Papers in
- Co-authors
- Yoshiaki Murakami (94 shared papers)Kenichiro Uemura (90 shared papers)Taijiro Sueda (90 shared papers)Yasushi Hashimoto (73 shared papers)Yasuo Hayashidani (43 shared papers)Hiroki Ohge (42 shared papers)Naru Kondo (38 shared papers)Akira Nakashima (25 shared papers)
- Journals
- Journal of Gastrointestinal Surgery (18 papers)Journal of Surgical Oncology (14 papers)Surgery (8 papers)World Journal of Surgery (8 papers)Gastroenterology (5 papers)
- Partner nations
- JapanUnited StatesRussia
In The Last Decade
Takeshi Sudo
136 papers receiving 3.7k citations
Takeshi Sudo's Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 3.0k
- Surgery 2.6k
- Pulmonary and Respiratory Medicine 1.6k
- Cancer Research 475
- Gastroenterology 150
Countries citing papers authored by Takeshi Sudo
This map shows the geographic impact of Takeshi Sudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Sudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Sudo more than expected).
Fields of papers citing papers by Takeshi Sudo
This network shows the impact of papers produced by Takeshi Sudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Sudo. The network helps show where Takeshi Sudo may publish in the future.
Co-authors
The 25 scholars most cited alongside Takeshi Sudo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 149 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01) Hit paper breakdown → | 2016 | 742 |
| 2 | 2010 | 182 | |
| 3 | 2010 | 134 | |
| 4 | 2010 | 130 | |
| 5 | 2009 | 96 | |
| 6 | 2007 | 88 | |
| 7 | 2009 | 75 | |
| 8 | 2007 | 75 | |
| 9 | 2006 | 70 | |
| 10 | 2007 | 65 | |
| 11 | 2009 | 62 | |
| 12 | 2010 | 58 | |
| 13 | 2009 | 54 | |
| 14 | 2008 | 51 | |
| 15 | 2014 | 51 | |
| 16 | 2012 | 50 | |
| 17 | 2012 | 47 | |
| 18 | 2014 | 47 | |
| 19 | 2013 | 45 | |
| 20 | 2015 | 45 |
About Takeshi Sudo
Takeshi Sudo is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology, having authored 149 papers that have together received 3.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (85 papers), Pancreatitis Pathology and Treatment (47 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers), Neuroendocrine Tumor Research Advances (31 papers), Gallbladder and Bile Duct Disorders (23 papers), Gastrointestinal Tumor Research and Treatment (9 papers), Gastrointestinal disorders and treatments (9 papers) and Gastric Cancer Management and Outcomes (8 papers). The work is most often cited by research in Oncology (3.0k citations), Surgery (2.6k citations), Pulmonary and Respiratory Medicine (1.6k citations), Cancer Research (475 citations) and Gastroenterology (150 citations). Takeshi Sudo has collaborated with scholars based in Japan, United States and Russia. Frequent co-authors include Yoshiaki Murakami, Kenichiro Uemura, Taijiro Sueda, Yasushi Hashimoto, Yasuo Hayashidani, Hiroki Ohge, Naru Kondo, Akira Nakashima, Naoya Nakagawa and Ryutaro Sakabe. Their work appears in journals such as Journal of Gastrointestinal Surgery, Journal of Surgical Oncology, Surgery, World Journal of Surgery and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.